Ulu Ventures

VC Palo Alto, United States · Founded 2008

Ulu Ventures is a seed-stage venture capital firm that utilizes a highly analytical, data-driven decision-making framework to reduce cognitive bias and actively invest in diverse, underrepresented founding teams.

About Ulu Ventures

Ulu Ventures is a Bay Area early-stage firm at uluventures.com with a Crunchbase profile and active LinkedIn presence, known for a disciplined seed-stage approach across enterprise software, fintech, and selective healthcare exposure. The firm has a public reputation for rigorous decision-analytic diligence and a portfolio that includes notable B2B and enterprise outcomes, which means founders should expect a structured, evidence-driven process rather than thesis-led conviction-on-vibes investing. For healthcare AI founders, Ulu is a credible candidate if you are building enterprise SaaS or AI infrastructure with healthcare as a primary or large secondary market, have clear early traction, and can articulate unit economics that survive scrutiny. Pure clinical-stage biotech, regulated devices, and capital-intensive therapeutic platforms are not a fit. Typical Ulu seed checks are in the USD 1M to USD 2M range, with selective follow-on. The firm is well syndicated with other Bay Area seed funds and tends to participate alongside named co-investors rather than leading every position. Geographic fit is strongest for US-anchored teams, particularly in Northern California, though Ulu has backed founders elsewhere. Best entry path is a warm introduction through a portfolio CEO or a Bay Area connector who can speak to your traction and team. When you do get the meeting, come prepared with cohort data, retention numbers, sales cycle metrics, and a clear competitive map; the firm’s process rewards founders who already think like operators rather than narrative pitchers.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Ulu Ventures

Tools made by companies in Ulu Ventures's portfolio that we cover in the directory.

Eko Foundation Analysis Software with Transformers (EFAST)
Eko Health
Cardiology AI
EFAST by Eko Health is an advanced, FDA-cleared AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams.
Eko Low Ejection Fraction Tool (ELEFT)
Eko Health
Cardiology AI
The Eko Low Ejection Fraction Tool (ELEFT) is an FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
IKS Health (Scribble Live)
IKS Health
Patient Engagement & Education
IKS Health's Agentic Platform unites clinical, operational, and financial workflows through agentic intelligence and human precision reducing friction, cutting costs, and improving care quality from day one. Empowered care teams reduce burden and restore focus with intuitive, clinically-guided solutions. Stronger financial performance maximizes revenue and prevents denials with intelligent, connected workflows. More efficient operations automate routine tasks and simplify administration through agentic AI.

Portfolio companies in our directory

Other portfolio companies

Companies in Ulu Ventures's portfolio not currently in our directory.

Team

Miriam Rivera
Cofounder, Managing Director
LinkedIn
Clint Korver
Cofounder, Managing Director
LinkedIn
Steve Reale
Partner, CFO
LinkedIn
Maria Salamanca
Partner
LinkedIn

Pitch / review this investor

Have you raised from Ulu Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.